skip to Main Content

Our Mission

Our mission is to pioneer the next wave of modern medicines to treat and cure the most significant diseases facing mankind today.

Our People

Ian Chan, MBA
CHIEF EXECUTIVE OFFICER  & CO-FOUNDER

Previously US Genomics, Morgan Stanley, Bear Stearns.
Education: AB Brown University, MBA Harvard University.

Eugene Chan, M.D.
CHAIRMAN  & CO-FOUNDER

Previously US Genomics.
Education: AB Harvard University, MD Harvard University.

Robert Markelewicz, Jr, MD, MMSc
SENIOR VICE PRESIDENT & CHIEF MEDICAL OFFICER

Previously Celgene, Acetylon, Parexel.
Education: ScB Brown University, MMSc Brown University, MD Brown University.

Scientific Advisory Board

Bob Langer, Ph.D.

Institute Professor at MIT with over 840 written articles and over 500 issued or pending patents. Founder of AIR, Momenta, Acusphere, Tempo Pharma, others.

Laurie Glimcher, M.D.

President and CEO of Dana-Farber Cancer Institute; Professor, Harvard Medical School

Rita Colwell, Ph.D.

Chairman, Canon Life Sciences; Former Director NSF, appointed by Bill Clinton.

Ronald Levy, M.D.

Professor of Medicine, Director of the Lymphoma Program, Former Chief of the Division of Oncology at Stanford University.

Shiv Pillai, M.D, Ph.D.

Professor of Medicine, Harvard Medical School

Nai-Kong Cheung, M.D, Ph.D.

Head, Neuroblastoma Program; Enid A. Haupt Chair in Pediatric Oncology

George C. Tsokos, M.D.

Professor of Medicine, Harvard Medical School. Chief, Rheumatology Division.

Board of Directors

Ian Chan, MBA

CHIEF EXECUTIVE OFFICER & CO-FOUNDER

Eugene Chan, M.D.

CHAIRMAN & CO-FOUNDER

Bob Langer, Ph.D.
Miles Suk

Our Collaborators

Back To Top